Cilomilast, a selective phosphodiesterase-4 inhibitor for treatment of patients with chronic obstructive pulmonary disease: a randomised, dose-ranging study

This publication has 14 references indexed in Scilit:

• Inhaled Glucocorticoids in Chronic Obstructive Pulmonary Disease
  New England Journal of Medicine, 2000
• Glucocorticoid Therapy for Chronic Obstructive Pulmonary Disease
  New England Journal of Medicine, 1999
• ArifloTM(SB 207499), a Second Generation Phosphodiesterase 4 Inhibitor for the Treatment of Asthma and COPD: from Concept to Clinic
  Pulmonary Pharmacology & Therapeutics, 1999
• Chronic obstructive pulmonary disease: new opportunities for drug development
  Trends in Pharmacological Sciences, 1998
• Phosphodiesterase Isozymes
  American Journal of Respiratory and Critical Care Medicine, 1998
• PHOSPHODIESTERASE INHIBITORS AND ENDOTHELIN AS MODULATORS OF RESPIRATORY NEUROTRANSMISSION
  Clinical and Experimental Pharmacology and Physiology, 1996
• Standardization of Spirometry, 1994 Update. American Thoracic Society.
  American Journal of Respiratory and Critical Care Medicine, 1995
• Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force
  European Respiratory Journal, 1995
• A Self-complete Measure of Health Status for Chronic Airflow Limitation: The St. George's Respiratory Questionnaire
  American Review of Respiratory Disease, 1992
• A sharper Bonferroni procedure for multiple tests of significance
  Biometrika, 1988